Japan secures 150 million Novavax vaccine doses via Takeda agreement
The Ministry of Health, Labour and Welfare has signed a deal with Takeda Pharmaceutical Company to purchase 150 million doses of the Novavax COVID-19 vaccine for domestic production and distribution starting in 2022.
Herald Premium Archive
This report is for subscribers
Sign in or choose a plan for full access to every Belfast Herald story and the complete archive.
HealthJapan secures 150 million Novavax vaccine doses via Takeda agreement
Sign in or subscribeBrowse free archive reportsThe Ministry of Health, Labour and Welfare has signed a deal with Takeda Pharmaceutical Company to purchase 150 million doses of the Novavax COVID-19 vaccine for domestic production and distribution starting in 2022.